announcement out - capital raising, page-46

I agree with microtrader:
"That was certainly not the trading halt I was hoping for... but I'll reserve judgement until the detail is released."

I also agree with mjshackl:
"OK, let's not blow our loads just yet. I am surprised to say in the least about the cap raising, but we do not know what the capital is intended for, so it is premature to say it is just to cover operating costs."

I have faith in the company and Nigel confirmed this morning with me that the statements he emailed me yesterday are true.
"We remain very happy with progress. Regarding the deal - I can assure you TIS is in the drivers seat because it's also a matter of who we want to have a strategic relationship and work with. Our objective is to do what is the most appropriate for successful future operations of the company and that is in our shareholders best interest."
"The Board and management continuously review the companies financial position and is happy with the cash position."

In my opinion, the capital raising announced this morning is not for the operating costs and would open better opportunities as mentioned in the following posts.

From rocksinhead:
"Well if someone wants in, and with a deal on the doorstep, and the cash position is OK, then they better be paying a premium to the current share price"

From supertramp:
"Hopefully the raising will be at a good price and already placed with some insto."

From chucksta:
"You know it could be a capital raising to major investors/institutions at $1++."

From TDA:
"One possibility for the raising is the potential desirability of Tissue Therapies running the regulatory approval process in each jurisdiction in their name and at their cost, this is also part of the commercial negotiations."

from greenisgood:
"Like most shareholders the last thing I expected (wanted) to see was a capital raising at this stage of the game. However, a capital raising could involve anything from a SPP at one end to a strategic stake being taken in the company by a large Biotech at the other end. Of course anything is possible in between. We have no choice but to wait, see and then judge."

From hopesprings:
"I am hoping it is a placement at a premium to a new key partner. That could be great news for TIS and the SP. It would need to be at least 80c and preferably over $1 a share."

From goggo:
"Any increase in the number of shares on issue might be achieved by the future partner taking a large equity position (hopefully at a premium) as well as current shareholders being offered an opportunity to increase their holdings."

In my opinion, since TIS is in the driver's seat and control the deal, one possibility is the capital raising is for regulatory aproval process (read TDA's post above).

Dr Steve Mercer said recently that the agreement is close. So, another possibility is the capital raising is for the potential partners/institutions.

Long term investors will get very rich in TIS. Short term investors do not have enough patience to enjoy future great rewards.